Results 271 to 280 of about 83,548 (314)
Some of the next articles are maybe not open access.

Tissue Plasminogen Activator (tPA)

2015
Tissue plasminogen activator (tPA) is used in the setting of acute ischemic stroke. tPA is also utilized for several additional thrombolytic indications, including acute MI, pulmonary embolism, and central venous catheter occlusion.
Juan E. Small   +2 more
openaire   +2 more sources

Efficacy and safety of tissue plasminogen activator

Neurosurgery, 1987
Simple aspiration to remove acute intracerebral hematomas has been thwarted by the solidity of the clot. Urokinase, a first generation fibrinolytic agent, has been used to liquefy such clots with some success. Therefore, tissue plasminogen activator (t-PA), a second generation fibrinolytic drug that may be safer and more effective, was studied to ...
David Bernstein   +4 more
openaire   +3 more sources

Content of Tissue Activator of Plasminogen in Monkey Tissues

Thrombosis and Haemostasis, 1957
SummaryThe content of the tissue activator of plasminogen in various organs from monkey is generally lower than in the corresponding human organs and approaches the concentration in the organs of other animals.
H. R Roberts, Tage Astrup
openaire   +3 more sources

Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator

Thrombosis Research, 1988
Glu-plasminogen (Glu-plg), Lys-plg and Val442-plg (mini-plg) were activated by urokinase (UK), streptokinase (SK) or tissue plasminogen activator (t-PA). Their activation rates were kinetically analyzed. UK activated Lys-plg with smaller Km and nearly identical Vmax as Glu-plg.
Yoshiaki Sugawara   +2 more
openaire   +2 more sources

Plasminogen activators and inhibitors in peritoneal tissue

APMIS, 1997
Serosal trauma elicits an inflammatory response which leads to the deposition of fibrin at injured sites, the residuals of which appear to be essential in excessive tissue repair and formation of intraabdominal adhesions. Local plasminogen activity may modulate this early phase of tissue repair.
Mårten Falkenberg   +3 more
openaire   +3 more sources

Tissue Plasminogen Activator and the Corneal Endothelium

American Journal of Ophthalmology, 1989
• There is a potential risk of bacterial or fungal contamination of the initial preparation, which could then result in contamination of each of the individual doses. It is essential, therefore, that the tissue plasminogen activator be reconstituted under strict aseptic conditions in a sterile hood.
Mark L. McDermott   +3 more
openaire   +3 more sources

Regulation of Tissue Plasminogen Activator Expression

Annual Review of Physiology, 1989
Widespread interest in the biology of the fibrinolytic system has developed with the recognition of the role of intravascular thrombosis in the pathogene­ sis of human disease. The therapeutic application of thrombolytic agents is a result of the rapid evolution of our understanding of the biochemistry and physiological importance of this system.
R S Meidell, Robert D. Gerard
openaire   +3 more sources

Tissue plasminogen activator

Neurology, 2007
Tissue-type plasminogen activator (tPA) is a serine protease that cleaves plasminogen into active plasmin. In plasma, the primary function of plasmin is the digestion of fibrin, and therefore, tPA is used as a thrombolytic agent for acute treatment of ischemic stroke.
openaire   +3 more sources

Ontogenesis of Tissue Plasminogen Activator in the Human

Thrombosis and Haemostasis, 1971
SummaryThe ontogenesis of tissue plasminogen activator in various tissues was studied in 10 embryos and 58 foetuses with a histochemical method.The first appearance of activator activity was seen in a 4-weeks old embryo. At 8-9 weeks it was seen in the eye, meninges, heart, lungs, kidney and vena cava. In the foetal heart high activity was found in the
Astedt B, Pandolfi M
openaire   +3 more sources

Tissue plasminogen activators in breast cancer

Thrombosis Research, 1987
Increased levels of tissue fibrinolytic activity have been detected in some malignant tumours and they have been implicated in metastatic spread. We have investigated tissue plasminogen activator (tPA) and urokinase (UK) in 26 breast carcinomas and 13 benign breast biopsies.
M. Pattison   +12 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy